{"id":"adh-1-and-docetaxel","safety":{"commonSideEffects":[{"rate":"50%","effect":"Neutropenia"},{"rate":"30%","effect":"Fatigue"},{"rate":"20%","effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"ADH-1 works by binding to heparin sulfate proteoglycans on the surface of endothelial cells, preventing the formation of new blood vessels. Docetaxel, on the other hand, binds to tubulin and prevents the polymerization of microtubules, thereby blocking cell division.","oneSentence":"ADH-1 is an angiostatic peptide that inhibits angiogenesis by binding to heparin sulfate proteoglycans on the surface of endothelial cells, while docetaxel is a microtubule inhibitor that blocks cell division.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T04:33:11.095Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Non-small cell lung cancer"}]},"trialDetails":[{"nctId":"NCT00390676","phase":"PHASE1","title":"A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine","status":"COMPLETED","sponsor":"Adherex Technologies, Inc.","startDate":"2006-11","conditions":"Neoplasms","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"ADH -1 and docetaxel","genericName":"ADH -1 and docetaxel","companyName":"Adherex Technologies, Inc.","companyId":"adherex-technologies-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ADH-1 is an angiostatic peptide that inhibits angiogenesis by binding to heparin sulfate proteoglycans on the surface of endothelial cells, while docetaxel is a microtubule inhibitor that blocks cell division. Used for Non-small cell lung cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}